Abstract:This review article provides a summary and update on the role of epigenetic mechanisms in predisposition and progression of diabetes, analyzes the data concerning the cause-and-effect relationship between epigenetic changes and the emergence of distinct metabolic phenotypes. Extensive genetic research has enabled the isolation of a group of genes associated with a high risk of developing diabetes. However, numerous data point to the key role of so-called epigenetic modifications in the interaction between genes and the environment, which arise during ontogenesis based on the existing genotype under the influence of external factors. These modifications do not affect the primary DNA sequence, but influence gene expression through chemical modification and alteration of the secondary structure of DNA molecules and chromatin. Epigenetic mechanisms can program pathological phenotypes in subsequent generations. The main molecular mechanisms of epigenetic modifications are DNA methylation, histone and miRNA modification. Changes in the expression of genes that ensure the synthesis of key enzymes and regulatory molecules lead to disruption in the main signaling metabolic pathways. Deregulation of genes responsible for inflammatory, atherosclerotic and other pathological processes, in particular, leads to endothelial dysfunction and development of diabetic complications, such as cardiovascular diseases, diabetic nephropathy, retinopathy, neuropathy. Hyperglycemia, oxidative stress, inflammatory factors are known as mediators in the pathogenesis of type 2 diabetes and its complications. Since epigenetic modifications are reversible, the methylation process can be influenced by exercise, dietary, lifestyle changes and pharmacological agents such as methyl group donors. For example, S-adenosylmethionine, through participation in methylation reactions, can modulate the folate cycle function and production of homocysteine, an endothelium-toxic substance. Thus, the study of molecular modifications in chromatin structure and the features of activation and inhibition of various signaling pathways is a pressing task, the resolution of which will enable a deeper understanding of the pathogenesis of diabetes and the development of approaches to correct metabolic disorders.

The role of epigenetic modification in glucose and lipid metabolism

Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study

Specific regulation of epigenome landscape by metabolic enzymes and metabolites

Roles of Lysine Methylation in Glucose and Lipid Metabolism: Functions, Regulatory Mechanisms, and Therapeutic Implications

Comprehensive Review on Lipid Metabolism and RNA Methylation: Biological Mechanisms, Perspectives and Challenges

Roles of Epigenetic Modifications in the Differentiation and Function of Pancreatic β-Cells

Development of Research on Regulation Mechanism of Epigenetic Modifications for Drug Metabolic Enzymes

The role of epigenetic modifications in the formation of heterogeneous phenotypes in diabetes mellitus (a literature review)

Roles of protein post-translational modifications in glucose and lipid metabolism: mechanisms and perspectives

Epigenetic regulation of energy metabolism in obesity

Update: the role of epigenetics in the metabolic memory of diabetic complications

Epigenetic regulation of adipose tissue expansion and adipogenesis by<i>N</i><SUP>6</SUP>-methyladenosine

Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications

The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes

Metabolic enzymes function as epigenetic modulators: A Trojan Horse for chromatin regulation and gene expression

Regulation of Glucose and Lipid Metabolism by Long Non-coding RNAs: Facts and Research Progress

Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics

Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes

A Recent Update on the Epigenetic Repertoire and Chromatin Modifying Therapy in Diabetes Mellitus: A Comprehensive Review

The Emerging Role of Epigenetics in Metabolism and Endocrinology

Abnormal lipid metabolism in metabolic syndrome: an epigenetic perspective